All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: Acquired Immunodeficiency Syndrome-17958917

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	17958917	R19S	Tat	Tat	Acquired Immunodeficiency Syndrome	G S	View
2	17958917	R40S	Tat	Tat	Acquired Immunodeficiency Syndrome	G S	View
3	17958917	R52W	Tat	Tat	Acquired Immunodeficiency Syndrome	G S	View
4	17958917	S70P	Tat	Tat	Acquired Immunodeficiency Syndrome	G S	View
5	17958917	T39I	Tat	Tat	Acquired Immunodeficiency Syndrome	G S	View
6	17958917	Y47H	Tat	Tat	Acquired Immunodeficiency Syndrome	G S	View
7	17958917	A21P	Tat	Tat	Acquired Immunodeficiency Syndrome	G S	View
8	17958917	A67V	Tat	Tat	Acquired Immunodeficiency Syndrome	G S	View
9	17958917	D68P	Tat	Tat	Acquired Immunodeficiency Syndrome	G S	View
10	17958917	D68S	Tat	Tat	Acquired Immunodeficiency Syndrome	G S	View
11	17958917	F32L	Tat	Tat	Acquired Immunodeficiency Syndrome	G S	View
12	17958917	H59P	Tat	Tat	Acquired Immunodeficiency Syndrome	G S	View
13	17958917	K28E	Tat	Tat	Acquired Immunodeficiency Syndrome	G S	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.